Brief: I'rom Group unit ID Pharma signs iPS cell generation technology licensing agreement with U.S.-based QurAlis

I'rom Co

02/02/2018 04:17

Feb 2(Reuters) - I'rom Group Co Ltd  2372.T  
     
    * Says its wholly owned unit ID Pharma concluded an iPS cell 
generation technology licensing agreement with U.S.-based 
QurAlis Corporation 
 
     
     
    Source text in Japanese:https://goo.gl/a2Qms7 
    Further company coverage: 2372.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724; 
Reuters Messaging: huafang.zhang.reuters.com@reuters.net))